Prestige 3 + WNV Equine Vaccine media thumbnails
Prestige 3 + WNV Equine Vaccine, 1ml
Prestige 3 + WNV Equine Vaccine, 10ml

Available Now! United States only — no international shipping!

Prestige 3 + WNV Equine Vaccine

Merck Animal Health SKU: 197924

$66.00

Shipping calculated at checkout

Size: 1-ml (1 Dose)
SHIPPING NOTICE: This product is Perishable! Requires Express shipping and is shipped Monday—Wednesday. Cannot be shipped to a PO Box.

Core Protection for WNV, EEE/WEE, and Tetanus

Product Description

Prestige 3 + WNV Equine Vaccine is a 4-way, killed vaccine for healthy horses 6 months of age and older. Prestige 3 + WNV helps protect against Eastern and Western equine encephalomyelitis, tetanus, and West Nile Virus. The combination supports core vaccination planning and helps reduce the impact of disease from mosquito-borne neurologic threats.

NOTICE: This item requires Express shipping due to the perishable nature of this product. Express orders are shipped Monday-Wednesday. Cannot be shipped to a PO Box. Product can only be shipped to the continental US.

Benefits

  • 4-Way Core Coverage: Helps protect against WNV, EEE, WEE, and tetanus.
  • Mosquito-Season Support: Supports protection against mosquito-borne West Nile disease risk.
  • Fewer Injections: Combination format reduces the need for separate core vaccines.
  • Trusted Formulation: Inactivated antigens with an adjuvant system for immune response.
  • Program Fit: Designed for routine annual vaccination programs and risk-based boosters.

Ingredients

Active Ingredients: Inactivated Eastern and Western equine encephalomyelitis viruses; West Nile virus (flavivirus chimera); tetanus toxoid.
Antibiotic: Gentamicin.
Preservative: Thimerosal.
Adjuvant: Havlogen® adjuvant.

How to Use

Dosage & Administration Instructions

  • Primary Series: Administer 1 mL intramuscularly, then repeat in 3-4 weeks.
  • Revaccination Note: Historically recommended annually; the need for this booster has not been established.
  • Foal Guidance: Maternal antibodies may interfere; additional boosters are required in most young animals.
  • Injection Route: Inject deep intramuscularly only.
  • Storage/Handling: Refrigerate 2°-8°C, shake well, and use entire contents when opened.

Additional Information

Precautions

  • Cold Storage: Store refrigerated at 2°-8°C (35°-46°F) and shake well.
  • Handling Rules: Use entire contents when opened; do not mix with other products.
  • Slaughter Timing: Do not vaccinate within 21 days before slaughter.
  • Reaction Monitoring: Local reactions may occur and often resolve within 3-7 days.
  • Allergic Response: Rare anaphylactoid reactions may require immediate treatment.

Shipping & Returns

We offer express delivery; see our shipping policy for details.

For return instructions or product concerns, please refer to our detailed refund policy.

Frequently Asked Questions

Q1: What does Prestige 3 + WNV Equine Vaccine protect against?

Ans: Prestige 3 + WNV Equine Vaccine helps protect healthy horses 6 months and older against Eastern and Western equine encephalomyelitis, tetanus, and West Nile Virus. The vaccine supports core immunization planning for diseases commonly included in annual equine vaccination programs.

Q2: What is the dosing schedule for Prestige 3 + WNV Equine Vaccine?

Ans: The primary series is 1 mL given intramuscularly, followed by a second 1 mL intramuscular dose in 3-4 weeks. After the initial series, revaccination timing should follow veterinary guidance and risk-based exposure planning.

Q3: When should horses receive West Nile vaccination during mosquito season?

Ans: West Nile protection is typically planned for peak mosquito activity, since immunity is stronger after completing the two-dose initial series. A veterinarian can recommend booster timing based on geographic risk, travel, and seasonal mosquito pressure.

Q4: Can foals receive this vaccine on the same schedule as adult horses?

Ans: Foals can have maternal antibodies that interfere with the development of active immunity. The label guidance notes that additional boosters may be required in most young animals. A veterinarian should determine the timing based on the foal's age, the dam's status, and the exposure risk.

Q5: Does the vaccine prevent disease or reduce the severity of West Nile Virus?

Ans: The indication supports vaccination against West Nile Virus as part of a preventive program. Protection depends on completing the recommended series and matching boosters to risk. Management practices that reduce mosquito exposure remain important alongside vaccination.

Q6: What side effects can occur after vaccination?

Ans: Local reactions such as swelling or soreness at the injection site can occur and commonly resolve within 3-7 days. Systemic reactions may occur as well. Rare allergic reactions are possible and should be addressed promptly with veterinary support.

Q7: How should Prestige 3 + WNV Equine Vaccine be stored and handled?

Ans: Store the vaccine refrigerated at 2°-8°C and shake well before use. Use the entire contents when first opened and do not mix with other products. Follow aseptic technique and administer by deep intramuscular injection only.

Q8: Can the vaccine be used during an outbreak or high-exposure conditions?

Ans: Label guidance indicates early revaccination may be advisable when horses are faced with an outbreak or conditions that make heavy exposure likely. A veterinarian should assess the situation and recommend whether additional boosters are appropriate.

Q9: Are there any key precautions for breeding horses or pregnant mares?

Ans:  Vaccine labels commonly note limited testing in pregnant animals for certain products, so a veterinarian should guide breeding decisions. A risk-benefit assessment should consider disease pressure, travel history, farm history, and timing within a broader vaccination schedule.